Business Context and Reporting Period
This Form 6-K/A filing by GlaxoSmithKline plc covers the period ending February 2015. The document serves as a notification of transactions involving directors and persons discharging managerial responsibility (PDMR) or connected persons, specifically regarding the sale of ordinary shares to meet tax liabilities.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific equity transaction rather than general financial performance.
- Share Sale Price: £15.4312 per Ordinary Share.
- Transaction Date: February 13, 2015.
- Shares Sold: 270 Ordinary Shares.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a routine transaction where a connected person sold shares to satisfy tax obligations following the vesting of awards granted in 2012 under the GlaxoSmithKline 2009 Performance Share Plan (PSP).
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is a compliance notification under Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the identity of the connected person (Mrs K Thomson) and the PDMR (Mr P Thomson) involved in the transaction.
- Confirm the total number of shares sold (270) and the price per share (£15.4312) against market data for February 13, 2015.
- Ensure the transaction was correctly classified as a sale to meet tax liabilities arising from the 2012 PSP award vesting.